Could a biodegradable device help heal spinal cords?

NCT ID NCT02490501

Completed Disease control Sponsor: BioArctic AB Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early-phase trial tested a device called SC0806, which is surgically implanted into the spine. It releases a growth factor to encourage nerve repair in people with complete spinal cord injury. Ten participants were randomly assigned to receive either the device plus rehabilitation or rehabilitation alone. The study looked at safety and whether the device could improve nerve signals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SC0806 (a biodegradable device containing heparin-activated recombinant fibroblast growth factor 1 and nerve implants)
What this could lead to: If successful, this could point toward a new treatment to help restore some nerve function after spinal cord injury.
What could go wrong: This is an early, small trial (10 people) focused on safety. It may not show meaningful improvement, and the surgery carries risks like infection or device complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPINAL CORD INJURY

Contacts and locations

Locations

Karolinska University Hospital and RSS

Stockholm, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.